Sheela Rao, MBBS, MD, FRCP, is a consultant medical oncologist specializing in gastrointestinal cancers and cancers of unknown primary within the gastrointestinal unit at the Royal Marsden Hospital.
With the FDA approval of retifanlimab (Zynyz; Incyte) as the first and only first-line treatment for advanced anal cancer, researchers are now focusing on resistance mechanisms and future therapies, according to Sheela Rao, MBBS, MD, FRCP, of The Royal Marsden Hospital.
259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.
